Can sentinel pelvic lymph node dissection replace extended pelvic lymph node dissection in patients with prostate cancer?
Günter Janetschek
Correspondence Department of Urology, Elisabethinen Hospital, Fadingerstra
e 1, 4010 Linz, Austria
Email guenter.janetschek@elisabethinen.or.at
Sentinel pelvic lymph node dissection is a radioisotope-guided technique that has been developed for the detection of potential lymph node metastases. In this Viewpoint, Professor Janetschek discusses the possibility that sentinel pelvic lymph node dissection could replace extended pelvic lymph node dissection in patients with prostate cancer.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.